| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RETA | REATA PHARMACEUTICALS INC | Ruff Shamim | Director | Jul 28, 2023 | Option Exercise | $92.20 | 8,235 | 759,267 | 15,594 | Aug 01, 2023, 04:41 PM | |
| RETA | REATA PHARMACEUTICALS INC | Ruff Shamim | Director | Jul 28, 2023 | Sale | $164.53 | 8,235 | 1,354,887 | 7,359 | Aug 01, 2023, 04:41 PM | |
| RETA | REATA PHARMACEUTICALS INC | Ruff Shamim | Director | Jun 07, 2023 | Option Exercise | $93.61 | 2,136 | 199,951 | 7,359 | Jun 09, 2023, 04:32 PM | |
| RETA | REATA PHARMACEUTICALS INC | Ruff Shamim | Director | Mar 10, 2023 | Option Exercise | $34.50 | 5,740 | 198,042 | 10,963 | Mar 13, 2023, 05:23 PM | |
| RETA | REATA PHARMACEUTICALS INC | Ruff Shamim | Director | Mar 10, 2023 | Sale | $83.73 | 5,740 | 480,610 | 5,223 | Mar 13, 2023, 05:23 PM | |
| RETA | REATA PHARMACEUTICALS INC | Ruff Shamim | Director | Jun 08, 2022 | Option Exercise | $34.76 | 5,105 | 177,450 | 5,223 | Jun 09, 2022, 04:47 PM | |
| RETA | REATA PHARMACEUTICALS INC | Ruff Shamim | Director | Jan 03, 2022 | Option Exercise | $27.32 | 118 | 3,224 | 118 | Jan 05, 2022, 04:04 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Chief Regulatory Affairs | May 22, 2018 | Option Exercise | $89.22 | 1,305 | 116,432 | 31,936 | May 24, 2018, 06:06 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Chief Regulatory Affairs | Mar 15, 2018 | Option Exercise | $81.22 | 736 | 59,778 | 28,809 | Mar 16, 2018, 06:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Chief Regulatory Affairs | Mar 15, 2018 | Option Exercise | $23.93 | 2,500 | 59,813 | 29,465 | Mar 16, 2018, 06:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 06, 2017 | Sale | $55.00 | 10,000 | 550,000 | 27,045 | Nov 08, 2017, 08:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 06, 2017 | Option Exercise | $14.76 | 10,000 | 147,600 | 37,045 | Nov 08, 2017, 08:13 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Oct 03, 2017 | Option Exercise | $14.76 | 11,500 | 169,740 | 38,545 | Oct 05, 2017, 07:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Oct 03, 2017 | Sale | $50.00 | 11,500 | 575,000 | 27,045 | Oct 05, 2017, 07:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Aug 03, 2017 | Option Exercise | $37.88 | 2,882 | 109,170 | 27,045 | Aug 07, 2017, 04:44 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 21, 2017 | Sale | $44.00 | 5,888 | 259,072 | 21,062 | Jul 21, 2017, 09:47 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 20, 2017 | Option Exercise | $13.71 | 6,250 | 85,688 | 27,312 | Jul 21, 2017, 09:47 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 20, 2017 | Sale | $42.00 | 6,250 | 262,500 | 21,062 | Jul 21, 2017, 09:47 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 21, 2017 | Option Exercise | $14.12 | 5,888 | 83,133 | 25,450 | Jul 21, 2017, 09:47 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Mar 19, 2017 | Option Exercise | $30.30 | 177 | 5,363 | 21,062 | Mar 21, 2017, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 08, 2016 | Option Exercise | $26.24 | 1,000 | 26,240 | 21,239 | Nov 10, 2016, 08:20 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Sep 22, 2016 | Sale | $60.00 | 7,311 | 438,660 | 20,239 | Sep 30, 2016, 09:58 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ruff Shamim | SVP, Regulatory Affairs & Qual | Sep 22, 2016 | Option Exercise | $13.90 | 7,311 | 101,623 | 27,550 | Sep 30, 2016, 09:58 PM |
Menu